Chu H, Lin Z, Zhong L et al
What might pricing look like
The possible reasons for the different effects of GLP-1RA on the occurrence of pancreatic cancer reported by different scholars are the differences in study groups, small sample sizes, insufficient follow-up times, and low incidence rates of events
In fact, more than half of respondents who use GLP-1 for weight loss (54%) said that insurance covered the entirety of the costs for the medications, while an additional 35% say that insurance covered at least some of the costs
Increases energy
Beyond diabetes management, certain GLP-1 receptor agonist medications have demonstrated cardiovascular benefits in clinical trials, though these benefits shouldn't be attributed to endogenous GLP-1 function alone